Document is current
Any future updates will be listed below
-
Authors
Seo, Woo-Young
Lee, Sang-Wook
Park, Yong-Seok
Kim, Hyun-Seok
Shin, Jae-Man
Kim, Dong-Kyu
Kim, Woo-Jin
Kim, Sung-Hoon https://orcid.org/0000-0001-5215-7585
-
Funding
Funding for this research was provided by:
Korea Health Industry Development Institute (HR20C0026, HI22C1723)
- License Information
-
More Information
Article History
Received: 11 February 2025
Revised: 3 May 2025
Accepted: 13 May 2025
First Online: 30 May 2025
Declarations
:
: Sung-Hoon Kim is the founder and stakeholder of Signal House Co., Ltd (Seoul, Korea). No other potential conflicts of interest relevant to this article was reported. Other authors have no conflicts of interest/financial disclosure.
: This study was performed in line with the principles of the Declaration of Helsinki and good clinical practice (GCP) guidelines. Approval was granted by the Asan Medical Center’s Institutional Review Board (IRB 2023-0318). The study was registered at the Clinical Research Information Service (CRIS), Republic of Korea (Registration number: KCT0009994, Principal Investigator: Yong-Seok Park, Date of registration: Nov-20-2023).
: Informed consent was obtained from all individual participants included in the study.
: The authors affirm that human research participants provided informed consent for publication of the images in Fig. .
